HHV-8 (13810); 1.0 ml catalog number 265M-16; 7.0 ml catalog number-265M-18; Microbiology - ...

FDA Device Recall #Z-2210-2017 — Class II — May 5, 2017

Recall Summary

Recall Number Z-2210-2017
Classification Class II — Moderate risk
Date Initiated May 5, 2017
Status Terminated
Voluntary Voluntary: Firm initiated

Recalling Firm

Firm Cell Marque Corporation
Location Rocklin, CA
Product Type Devices
Quantity 11

Product Description

HHV-8 (13810); 1.0 ml catalog number 265M-16; 7.0 ml catalog number-265M-18; Microbiology - Analyte Specific Reagent In vitro diagnostic use - Analyte Specific Reagent

Reason for Recall

Cell Marque has determined the need to issue a product recall after identifying product intended to be sold outside the U.S. was not properly labeled as "For Export Only" as required by section 801 (e )(1) of the FD&C Act.

Distribution Pattern

Nationwide Distribution to CA, CO, DE, FL, GA, IL, KY, MD, MA, MS, NJ, NY, NC, OH, OK, OR, PA, TX.

Lot / Code Information

1.0 ml lot 1626403D, expiry 2019-08; 7.0 mL lot. 1625207H, expiry 2019-08;

Other Recalls from Cell Marque Corporation

Recall # Classification Product Date
Z-2311-2021 Class III Cell Marque Antibodies, PSA (ER-PR8) Mouse Mono... Jul 15, 2021
Z-2105-2021 Class II Cell Marque, RabMAb,CD17, c-kit (YR145) Rabbit ... May 27, 2021
Z-2106-2021 Class II Cell Marque Antibodies, MSH6 (44), Mouse Monocl... May 27, 2021
Z-2202-2017 Class II H. pylori (polyclonal} 1.0 mL Catalog number 2... May 5, 2017
Z-2208-2017 Class II Varicella Zoster Virus 7.0 ml catalog number 3... May 5, 2017

Frequently Asked Questions

Contact your healthcare provider and the device manufacturer immediately. Check whether your specific model number and lot number are included in the recall scope. For external devices, stop using the affected product and arrange a replacement. For implanted devices, do not panic — removal is typically not required unless the risk assessment clearly indicates it. Your physician will guide you based on your individual clinical situation and the FDA's recommended actions. Report any adverse effects you may have experienced to FDA MedWatch at 1-800-FDA-1088.

Class I recalls indicate a reasonable probability of serious adverse health consequences or death from the defect. Class II recalls involve products that may cause temporary or medically reversible adverse health consequences, or where serious consequences are remote. Class III recalls cover products not likely to cause any adverse health consequences, typically involving technical regulatory violations. The classification guides urgency — Class I recalls require immediate action, while Class III may simply involve returning a product or acknowledging a labeling change. Always read the specific recall notice for recommended patient actions.

Report problems with medical devices to the FDA through MedWatch at 1-800-FDA-1088 or online at FDA.gov/safety/medwatch. Healthcare facilities are required by law to report device-related serious injuries and deaths. Patients and consumers can also report voluntarily. Include the device name, manufacturer, model number, and a description of the problem and any patient outcome. Reports from patients and clinicians help the FDA identify emerging safety signals and may trigger investigations that lead to recalls of dangerous devices.

What Should You Do?

Stop using this device if you are affected by this recall. Contact your healthcare provider and the manufacturer immediately for guidance. Report adverse events to FDA MedWatch.